60 Degrees Pharmaceuticals (SXTP) Balance Sheet: Assets & Liabilities

60 Degrees Pharmaceuticals (SXTP) Balance Sheet

As of Mar 31, 2026 (end of fiscal 2025), 60 Degrees Pharmaceuticals reported total assets of $5.37M and total liabilities of $1.99M. Shareholders' equity was $3.46M, down 14.2% from $4.04M a year earlier. Total debt stood at $152.78K against $2.75M in cash and short-term investments, a net cash position of $2.60M. That puts debt-to-equity at 0.04, compared with 0.04 a year earlier.

60 Degrees Pharmaceuticals Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for 60 Degrees Pharmaceuticals, Inc. (SXTP) - Annual data in millions USD
Breakdown	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period ending	Mar 2026	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	1.51	1.51	1.66	2.14	0.26	0.12	0.19
Short-Term Investments	1.24	1.24	1.73	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	2.75	1.51	3.39	2.14	0.26	0.12	0.19
Accounts Receivable	0.51	0.51	0.49	0.23	0.05	0.15	0.86
Inventory	0.66	0.66	0.44	0.47	0.52	0.69	1.04
Other Current Assets	0.98	0.98	1.07	4.40	0.20	0.23	0.35
Total Current Assets	4.90	4.90	5.39	7.24	1.10	1.18	2.44
Non-Current Assets
Property, Plant & Equipment (Net)	0.25	0.25	0.15	0.07	0.03	0.11	0.07
Intangible Assets	0.22	0.22	0.16	0.23	0.16	0.11	0.08
Other Non-Current Assets	0.00	-	0.07	0.24	0.00	0.00	0.01
Total Non-Current Assets	0.47	0.47	0.37	0.54	0.20	0.22	0.16
Total Assets	5.37	5.37	5.76	7.78	1.30	1.39	2.61
Current Liabilities
Accounts Payable	1.46	1.46	1.01	0.51	0.76	0.59	1.38
Short-Term Debt	0.01	0.01	0.01	0.01	21.14	0.14	0.00
Current Portion of Long-Term Debt	-	-	0.01	0.01	21.14	-	-
Accrued Liabilities	-	-	-	-	-	-	0.00
Deferred Revenue	0.00	-	0.00	0.00	0.33	0.00	0.00
Other Current Liabilities	0.37	0.37	0.64	2.31	1.49	-0.09	0.05
Total Current Liabilities	1.84	1.84	1.66	2.84	23.92	0.64	1.43
Non-Current Liabilities
Long-Term Debt	0.14	0.14	0.15	0.15	1.27	18.76	19.14
Other Non-Current Liabilities	0.00	-	0.00	0.00	0.25	0.15	0.10
Total Non-Current Liabilities	0.14	0.14	0.15	0.15	1.53	18.91	19.24
Total Liabilities	1.99	1.99	1.80	2.99	25.45	19.55	20.68
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	4.98	0.80
Retained Earnings	-47.89	-47.89	-40.53	-32.58	-28.82	-22.63	-18.38
Accumulated Other Comprehensive Income	0.14	0.14	0.14	0.14	0.07	0.08	0.08
Additional Paid-in Capital	41.65	41.65	34.86	27.46	5.16	0.00	0.00
Minority Interest	-0.08	-0.08	-0.08	-0.07	-0.57	-0.58	-0.57
Shares Outstanding	-	1.16	0.14	0.02	0.02	0.02	-
Total Stockholders' Equity	3.46	3.46	4.04	4.80	-23.58	-17.58	-18.07
Total Liabilities & Equity	5.37	5.37	5.76	7.78	1.30	1.39	2.61

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About 60 Degrees Pharmaceuticals Balance Sheet

How much debt does 60 Degrees Pharmaceuticals have?

60 Degrees Pharmaceuticals had total debt of $152.78K as of Mar 31, 2026, against $2.75M in cash and short-term investments. Its debt-to-equity ratio was 0.04. Total debt was $155.89K a year earlier.

What are 60 Degrees Pharmaceuticals's total assets?

60 Degrees Pharmaceuticals reported total assets of $5.37M as of Mar 31, 2026, down 6.8% from $5.76M a year earlier. Total liabilities were $1.99M.

What is 60 Degrees Pharmaceuticals's shareholders' equity?

60 Degrees Pharmaceuticals's shareholders' equity was $3.46M as of Mar 31, 2026.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition